COVID-19 is a major stressor for the healthcare system. Many health systems around the world were on the verge of collapse due to the reduction of semi-elective and elective services. In many developed countries, the United States performed worse. The population is reluctant to vaccinations and public health measures. We are today 68The th In the world The number of people who have received a COVID-19 vaccine has increased. In the United States, a private health care system is managed to maximize financial efficiency. The system is characterized by a just-in-time supply chain and has been plagued by a nursing shortage for many decades.

Dr Kevin Kavanagh

health: the main players are calling for a programming law
Read moreHealth: the main players demand a programming law

But there is little evidence of action. Free market forces and consumer choice have been cited as determining factors in the quality of health care. But transparency and accountability must be at the forefront of any effort to improve them.

The United States publishes hospital quality indicators. Hospital Compare. The data generated by these measures is used to educate consumers and in federal incentive programs. Hospitals can either be penalized for poor performance or rewarded depending on the program.

The U.S. health care system was on the brink of collapse during the COVID-19 outbreak, largely due to understaffing and insufficient supplies. Instead of transformation, policymakers appear to have assumed that there is little hospitals can do to avoid COVID-19 security breaches. Centers for Medicare & Medicaid The (CMS). “Risk” adjusted quality indicators. Financial incentives. COVID-19 data has been removed from nearly all measures of hospital-acquired conditions (HAC), Hospital Value-Based Purchasing (VBP), and Hospital Readmissions Reduction Programs (HRRP) for FY 2023. The VBP program also paused the health system's consumer rating system.

That would represent a significant portion of Americans, perhaps even half. Since no one counts, no one knows.

Exclusion from the Readmissions Reduction Program is for any patient with pneumonia who was diagnosed with COVID-19 at the time of admission. In 2024, the COVID-19 risk of the six monitored readmission procedures will be adjusted for a history of COVID-19 within the past 12 months. This would affect a significant portion of Americans, perhaps even half. Nobody knows the truthSince no one really matters (see Interview with Frazier Batty).

Additionally, the CDC National Healthcare Safety Network (NHSN) five hospital-acquired infection metrics for the HAC reduction program are Deletion for fiscal years 2023 and 2024.

Major news media outlets report on the performance of these incentive programs.

The public is unaware of the serious and frequent after-effects that COVID-19 can cause. However, healthcare institutions are aware of the risk and do not include undesirable consequences in their financial incentive programs.

COVID-19 is a new way of life that requires investment and strategic planning to mitigate risks.

Learning to live with COVID-19 does not mean accepting a higher rate of death and disability. To learn to live with COVID-19, you must invest and develop strategies to minimize risks and unwanted consequences.

The question we asked was: was the high incidence of adverse events experienced by COVID-19 patients an inevitable consequence or a system failure that could have been avoided? Risk adjustment would not be advisable if system failure was the cause of the high adverse event rate. This would only normalize deviance and penalize hospitals that invest in prevention.

VA Hospital

Image Public domain

Answering this question is easy. in our recent articleWe compared the rates of MRSA-related hospital infections recorded by the CDC NHSN system with the private health sector rate. We were surprised to see a 100 percent difference. In the VHA, rates were 83.6 % lower than the private sector benchmark rate.

Many will say that this comparison is apples to oranges. COVID-19 patients treated with VHA At the height of the pandemic, even non-veterans in the private sector were hospitalized. HAV patients are at higher risk Older population The average number of patients served in the private sector is lower.

Patients will not develop MRSA if they have not been exposed to it. Many of our private sector hospitals have experienced severe staffing shortages during COVID-19 and have filled entire wards with temporary or agency nurses unfamiliar with hospital protocol and hospital electronic medical records systems. Contrary to VHA staff deployed to assist non-VHA patients Private facilities are also available.

Prevention of infectious diseases, such as COVID-19 or MRSA, requires active surveillance.

COVID-19 or not, active surveillance is essential to prevent infectious diseases. CRE You can also learn more about MRSA. Staffing is expensive and difficult to maintain for active surveillance protocols and other prevention measures. Our private healthcare system was not equipped to deal with the COVID-19 outbreak due to staffing shortages before the pandemic. Bacterial infection rates have increased.

COVID-19 will not go away. We may enter an endemic or status quo phase, which will require us to provide services to a high volume of patients. The U.S. healthcare system is under constant strain as new strains constantly emerge and a growing number of Americans refuse to follow public health advice and get vaccinated.

Only when there is no effective way to avoid undesirable consequences should risk adjustment be resorted to. We must ask ourselves: will we rise to this challenge and build the infrastructure necessary to strengthen our health system to adapt to the new normal, or will we normalize the gaps with reduced staffing, fair supply chains on time and continued deviance? I would choose to use financial incentives and rewards as a way to drive change.

On the Health home page: see all the most recent articles